Skip to main content
Print Save

Kesimpta Prices, Coupons and Patient Assistance Programs

Kesimpta (ofatumumab) is a member of the CD20 monoclonal antibodies drug class and is commonly used for Multiple Sclerosis.

The cost for Kesimpta subcutaneous solution (20 mg/0.4 mL) is around $8,606 for a supply of 0.4 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Kesimpta prices

Subcutaneous Solution

Kesimpta Coupons, Copay Cards and Rebates

Kesimpta offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Kesimpta $0 Access Card: Eligible commercially insured patients may pay as little as $0 per prescriptions when enrolled in the program; $18,000 maximum savings per year; for more information contact the program at 855-537-4678.

Applies to:
Kesimpta
Number of uses:
Per prescription per year

Form more information phone: 855-537-4678 or Visit website

Kesimpta Access Bridge Program: Eligible commercially insured patients who receive an initial denial for coverage may receive up to 12 months of free product while coverage is pursued; for more information contact the program at 855-537-4678.

Applies to:
Kesimpta
Number of uses:
Temporary Assistance

Form more information phone: 855-537-4678 or Visit website

Patient Assistance & Copay Programs for Kesimpta

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Novartis Patient Assistance Foundation, Inc. (NPAF)

Eligibility requirements:
  1. Contact program for details.
  2. Based on FPL
  3. Not specified
  4. Must be residing in the US or US territory
  5. Novartis Oncology Products: To start the application process apply to PANO (Patient Assistance Now Oncology) at www.patient.novartisoncology.com or (800) 282-7630. Kesimpta: To start the application process apply to Alongside
Applicable drugs:
  • Kesimpta (ofatumumab) Injection; Subcutaneous

More information please phone: 800-277-2254 Visit Website

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Kesimpta (ofatumumab) Injection; Subcutaneous

More information please phone: 866-316-7263 Visit Website

Provider: Alongside KESIMPTA Program

Eligibility requirements:
  1. Contact program for details.
  2. Determined case by case
  3. Medically Necessary as determined by a Doctor
  4. US residency requirements are not specified.
  5. Co-payment assistance, patient support, and patient assistance programs are available for eligible patients. This program may provide a Bridge Program for eligible patients. Contact program for details.
Applicable drugs:
  • Kesimpta (ofatumumab) Injection; Subcutaneous

More information please phone: 855-537-4678 Visit Website